Pluristem Therapeutics Inc.

Pluristem Therapeutics Inc. - Enterprise Valueverified

PSTI

Price:

$1

Market Cap:

$40.85M

Pluristem Therapeutics Inc., an Israeli biotechnology firm founded in 2001 and based in Haifa, specializes in the discovery, advancement, clinical assessment, and production of innovative cell-based therapeutic products. The company's primary focus is on addressing a spectrum of severe medical conditions, including those related to reduced blood flow (ischemia), inflammation, blood disorders, and autoimmune dysfunctions, using its proprietary technologies. A cornerstone of their product pipeline involves placental expanded (PLX) based cell therapies. Their leading investigational drug, PLX-PAD, is currently undergoing evaluation in several clinical studies: it's in a late-stage (Phase III) t...[Read more]

Industry

Biotechnology

IPO Date

2007-12-10

Stock Exchange

NASDAQ

Ticker

PSTI

The Enterprise Value as of September 2026 (TTM) for Pluristem Therapeutics Inc. (PSTI) is 44.80M

According to Pluristem Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 44.80M. This represents a change of -16.15% compared to the average of 53.43M of the last 4 quarters.

Pluristem Therapeutics Inc. (PSTI) Historical Enterprise Value (quarterly & annually)

How has PSTI Enterprise Value performed in the past?

The mean historical Enterprise Value of Pluristem Therapeutics Inc. over the last ten years is 108.07M. The current 44.80M Enterprise Value has changed 4.05% with respect to the historical average. Over the past ten years (40 quarters), PSTI's Enterprise Value was at its highest in in the September 2020 quarter at 263.70M. The Enterprise Value was at its lowest in in the December 2024 quarter at 11.05M.

Quarterly (TTM)
Annual

Average

108.07M

Median

105.94M

Minimum

13.70M

Maximum

193.67M

Pluristem Therapeutics Inc. (PSTI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pluristem Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 124.56%

Maximum Annual Enterprise Value = 193.67M

Minimum Annual Increase = -78.68%

Minimum Annual Enterprise Value = 13.70M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202613.70M-78.68%
202564.24M-38.63%
2021104.67M-32.11%
2020154.18M124.56%
201968.66M-42.95%
2018120.35M12.27%
2017107.20M7.66%
201699.58M-35.55%
2015154.49M-20.23%
2014193.67M22.07%

Pluristem Therapeutics Inc. (PSTI) Average Enterprise Value

How has PSTI Enterprise Value performed in the past?

The current Enterprise Value of Pluristem Therapeutics Inc. (PSTI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

60.87M

5-year avg

81.09M

10-year avg

108.07M

Pluristem Therapeutics Inc. (PSTI) Enterprise Value vs. Peers

How is PSTI’s Enterprise Value compared to its peers?

Pluristem Therapeutics Inc.’s Enterprise Value is greater than Magenta Therapeutics, Inc. (-66820976.00), greater than Rein Therapeutics Inc. (13.52M), less than Eyenovia, Inc. (51.87M), greater than Satsuma Pharmaceuticals, Inc. (20.18M), greater than Lumos Pharma, Inc. (3.04M), greater than Lunai Bioworks Inc. (8.57M), less than GreenLight Biosciences Holdings (57.81M), greater than Cerecor Inc. (-46510587.00), greater than LianBio (-2838467.00), greater than AlloVir, Inc. (27.20M),

CompanyEnterprise ValueMarket cap
-66820976.00$42.44M
13.52M$22.06M
51.87M$38.59M
20.18M$36.47M
3.04M$37.54M
8.57M$32.92M
57.81M$45.43M
-46510587.00$38.63M
-2838467.00$6.55M
27.20M$49.48M

Build a custom stock screener for Pluristem Therapeutics Inc. (PSTI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pluristem Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pluristem Therapeutics Inc. (PSTI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pluristem Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Pluristem Therapeutics Inc.'s Enterprise Value?

What is the highest Enterprise Value for Pluristem Therapeutics Inc. (PSTI)?

What is the 3-year average Enterprise Value for Pluristem Therapeutics Inc. (PSTI)?

What is the 5-year average Enterprise Value for Pluristem Therapeutics Inc. (PSTI)?

How does the current Enterprise Value for Pluristem Therapeutics Inc. (PSTI) compare to its historical average?